CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- 4 Open-market buy Chief Executive Officer bought 6,993 shares at $1.43 ($10,000)
- 4 Open-market buy Director bought 20,979 shares at $1.43 ($30,000)
- 4 Open-market buy Director bought 6,993 shares at $1.43 ($10,000)
- 4 Open-market buy Director bought 17,483 shares at $1.43 ($25,001)
- 4 Open-market buy Director bought 69,930 shares at $1.43 ($100,000)
- 4 Open-market buy Director bought 10,490 shares at $1.43 ($15,001)
- 4 Open-market buy Director bought 13,986 shares at $1.43 ($20,000)
- 4 Open-market buy Director bought 447,761 shares at $1.34 ($600,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Scientific Officer gave up 116 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 552 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 466 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 461 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 15 · 300 filings